These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23918612

  • 1. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E, Amoui M, Mirzaee HR, Tabei F, Rakhsha A, Kalantari BA, Shafiei B, Assadi M, Asli IN.
    J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
    [Abstract] [Full Text] [Related]

  • 2. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S.
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [Abstract] [Full Text] [Related]

  • 3. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K, Hliscs R, Kropp J, Runge R, Knapp FF, Franke WG.
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [Abstract] [Full Text] [Related]

  • 4. Systemic radionuclide therapy in pain palliation.
    Liepe K, Runge R, Kotzerke J.
    Am J Hosp Palliat Care; 2005 Jun; 22(6):457-64. PubMed ID: 16323716
    [Abstract] [Full Text] [Related]

  • 5. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
    Maxon HR, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, Samaratunga RC, Libson KF, Williams CC, Moulton JS.
    Radiology; 1990 Jul; 176(1):155-9. PubMed ID: 1693784
    [Abstract] [Full Text] [Related]

  • 6. The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cheng A, Chen S, Zhang Y, Yin D, Dong M.
    Cancer Biother Radiopharm; 2011 Apr; 26(2):237-44. PubMed ID: 21539455
    [Abstract] [Full Text] [Related]

  • 7. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH, Souvatzoglou MA, Rapti AS, Leontopoulou SA, Papadaki EK, Datseris EI, Anagnostopoulou US, Zerva CJ.
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [Abstract] [Full Text] [Related]

  • 8. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
    de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, Quirijnen JM, Blijham GH, van Rijk PP.
    J Nucl Med; 1996 Feb; 37(2):244-9. PubMed ID: 8667053
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.
    Kolesnikov-Gauthier H, Carpentier P, Depreux P, Vennin P, Caty A, Sulman C.
    J Nucl Med; 2000 Oct; 41(10):1689-94. PubMed ID: 11037999
    [Abstract] [Full Text] [Related]

  • 10. Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
    Zhang H, Tian M, Li S, Liu J, Tanada S, Endo K.
    Cancer Biother Radiopharm; 2003 Oct; 18(5):719-26. PubMed ID: 14629820
    [Abstract] [Full Text] [Related]

  • 11. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ.
    J Nucl Med; 1991 Oct; 32(10):1877-81. PubMed ID: 1717669
    [Abstract] [Full Text] [Related]

  • 12. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R, Festa A, Pasqualoni R, Semprebene A, Rea S, Bergomi S, Maini CL.
    Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 14. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R, Séra T, Pajor L, Thurzó L, Láng J, Csernay L, Pávics L.
    Orv Hetil; 2000 May 07; 141(19):1019-23. PubMed ID: 10846424
    [Abstract] [Full Text] [Related]

  • 15. 186Re-HEDP for metastatic bone pain in breast cancer patients.
    Lam MG, de Klerk JM, van Rijk PP.
    Eur J Nucl Med Mol Imaging; 2004 Jun 07; 31 Suppl 1():S162-70. PubMed ID: 15118846
    [Abstract] [Full Text] [Related]

  • 16. Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases.
    Sciuto R, Tofani A, Festa A, Giannarelli D, Pasqualoni R, Maini CL.
    J Nucl Med; 2000 Apr 07; 41(4):647-54. PubMed ID: 10768566
    [Abstract] [Full Text] [Related]

  • 17. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K, Runge R, Kotzerke J.
    J Cancer Res Clin Oncol; 2005 Jan 07; 131(1):60-6. PubMed ID: 15449184
    [Abstract] [Full Text] [Related]

  • 18. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
    Han SH, De Klerk JM, Zonnenberg BA, Tan S, Van Rijk PP.
    Q J Nucl Med; 2001 Mar 07; 45(1):84-90. PubMed ID: 11456380
    [Abstract] [Full Text] [Related]

  • 19. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
    Lange R, Overbeek F, de Klerk JM, Pasker-de Jong PC, van den Berk AM, Ter Heine R, Rodenburg CJ, Kooistra A, Hendrikse NH, Bloemendal HJ.
    Nuklearmedizin; 2016 Sep 26; 55(5):188-95. PubMed ID: 27443809
    [Abstract] [Full Text] [Related]

  • 20. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO, Ibiş E, Aras G, Baltaci S, Ozalp G, Bedük Y, Canakci N, Soylu A.
    Ann Nucl Med; 2000 Aug 26; 14(4):239-45. PubMed ID: 11023023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.